Items where Author is "Haddad, Vincent"
![]() | Up a level |
Article
Goekbuget, Nicola and Dombret, Herve and Bonifacio, Massimiliano and Reichle, Albrecht and Graux, Carlos and Faul, Christoph and Diedrich, Helmut and Topp, Max S. and Brueggemann, Monika and Horst, Heinz-August and Havelange, Violaine and Stieglmaier, Julia and Wessels, Hendrik and Haddad, Vincent and Benjamin, Jonathan E. and Zugmaier, Gerhard and Nagorsen, Dirk and Bargou, Ralf C. (2018) Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia. BLOOD, 131 (14). pp. 1522-1531. ISSN 0006-4971, 1528-0020
Other
Goekbuget, Nicola and Dombret, Herve and Bonifacio, Massimiliano and Reichle, Albrecht and Graux, Carlos and Faul, Christoph and Diedrich, Helmut and Topp, Max S. and Brueggemann, Monika and Horst, Heinz A. and Stieglmaier, Julia and Wessels, Hendrik and Haddad, Vincent and Zugmaier, Gerhard and Nagorsen, Dirk and Bargou, Ralf C. (2015) Long-Term Outcomes after Blinatumomab Treatment: Follow-up of a Phase 2 Study in Patients (Pts) with Minimal Residual Disease (MRD) Positive B-Cell Precursor Acute Lymphoblastic Leukemia (ALL). AMER SOC HEMATOLOGY, WASHINGTON.
Goekbuget, Nicola and Dombret, Herve and Bonifacio, Massimiliano and Reichle, Albrecht and Graux, Carlos and Havelange, Violaine and Buss, Eike C. and Faul, Christoph and Bruggemann, Monika and Ganser, Arnold and Stieglmaier, Julia and Wessels, Hendrik and Haddad, Vincent and Zugmaier, Gerhard and Nagorsen, Dirk and Bargou, Ralf C. (2014) BLAST: A Confirmatory, Single-Arm, Phase 2 Study of Blinatumomab, a Bispecific T-Cell Engager (BiTE (R)) Antibody Construct, in Patients with Minimal Residual Disease B-Precursor Acute Lymphoblastic Leukemia (ALL). AMER SOC HEMATOLOGY, WASHINGTON.

